BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18265124)

  • 1. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.17. PubMed ID: 18265124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.13. PubMed ID: 18429179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Protein Sci; 2017 Aug; 89():5.13.1-5.13.18. PubMed ID: 28762491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Mol Biol; 2017 Jan; 117():16.17.1-16.17.18. PubMed ID: 28060405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Microbiol; 2015 Nov; 39():14A.4.1-14A.4.18. PubMed ID: 26528782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Easy and efficient protocols for working with recombinant vaccinia virus MVA.
    Kremer M; Volz A; Kreijtz JH; Fux R; Lehmann MH; Sutter G
    Methods Mol Biol; 2012; 890():59-92. PubMed ID: 22688761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonreplicating vaccinia vector efficiently expresses recombinant genes.
    Sutter G; Moss B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10847-51. PubMed ID: 1438287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of isolating and selecting recombinant vaccinia viruses expressing heterogenetic viral antigens].
    Gibadulin RA; Iuferov VP; Lideman LF; Parasiuk NA; Ionova KS
    Vopr Virusol; 1988; 33(4):428-31. PubMed ID: 3057744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.
    Di Lullo G; Soprana E; Panigada M; Palini A; Erfle V; Staib C; Sutter G; Siccardi AG
    J Virol Methods; 2009 Mar; 156(1-2):37-43. PubMed ID: 19038289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.
    Di Lullo G; Soprana E; Panigada M; Palini A; Agresti A; Comunian C; Milani A; Capua I; Erfle V; Siccardi AG
    J Virol Methods; 2010 Feb; 163(2):195-204. PubMed ID: 19778556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Design and construction of transfer vectors in order to obtain recombinant modified vaccinia virus Ankara (MVA)].
    Ferrer MF; Zanetti FA; Calamante G
    Rev Argent Microbiol; 2007; 39(3):138-42. PubMed ID: 17987847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early gene expression of vaccinia virus strains replicating (Praha) and non-replicating (modified vaccinia virus strain Ankara, MVA) in mammalian cells.
    Nemecková S; Hainz P; Otáhal P; Gabriel P; Sroller V; Kutinová L
    Acta Virol; 2001; 45(4):243-7. PubMed ID: 11885931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and isolation of recombinant MVA.
    Staib C; Drexler I; Sutter G
    Methods Mol Biol; 2004; 269():77-100. PubMed ID: 15114009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara].
    Zheng Q; Bi Z; Li M; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of recombinant vaccinia viruses and their products.
    Earl PL; Moss B
    Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.18. PubMed ID: 18265125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of chimeric vaccinia viruses by molecular cloning and packaging.
    Scheiflinger F; Dorner F; Falkner FG
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9977-81. PubMed ID: 1438247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recombinant vaccinia viruses and their products.
    Earl PL; Moss B
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.14. PubMed ID: 18429180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and biological characteristic for the recombinant modified vaccinia virus ankara co-expressing modified GP5 and M protein of porcine reproductive and respiratory syndrome virus].
    Zheng Q; Li P; Cao R; Hou J; Chen P
    Sheng Wu Gong Cheng Xue Bao; 2008 May; 24(5):766-73. PubMed ID: 18724695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Cell Cultures and Vaccinia Virus Stocks.
    Cotter CA; Earl PL; Wyatt LS; Moss B
    Curr Protoc Mol Biol; 2017 Jan; 117():16.16.1-16.16.18. PubMed ID: 28060410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and isolation of recombinant vaccinia virus using genetic markers.
    Lorenzo MM; Galindo I; Blasco R
    Methods Mol Biol; 2004; 269():15-30. PubMed ID: 15114004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.